It is recommended that this study be expanded to include large populations of all types of acute coronary syndromes, patients are followed for longer periods of time, markers are dynamically analyzed, and more experimental studies of MPO-targeting inhibitors are needed for early clinical application. The gene discussed is MPO; the disease is acute coronary syndrome.